Young women with a history of cervical lesions are at 20% higher risk of developing cardiovascular disease and more likely to die from it, compared to others their age without the condition.
Milestone approval advances a new category of artificial cervical disc technology uniquely engineered to preserve motion and improve spinal ...
Synergy Spine Solutions announced today that it received FDA premarket approval (PMA) for its Synergy Disc for 1-level indications at C3-C7.
THE Health Technology Assessment (HTA) unit of the Department of Science and Technology (DOST) is currently assessing 13 advanced breast and cervical cancer treatments as part of ongoing efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results